The association between intermittent preventive treatment uptake and anaemia amongst pregnant women in Zambia in 2018: a spatial analysis

dc.contributor.authorChisiba, Charlotte
dc.contributor.supervisorMusenge, Eustasius
dc.contributor.supervisorMapuroma, Relebogile
dc.date.accessioned2024-11-20T09:01:50Z
dc.date.available2024-11-20T09:01:50Z
dc.date.issued2024
dc.descriptionA research report submitted in partial fulfillment of the requirements for the degree of Master of Science in Epidemiology (Implementation Science) to the Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg 2024
dc.description.abstractBackground: This study investigated the association between Intermittent Preventive Treatment with Sulphadoxine Pyrimethamine (IPTp-SP) uptake and anaemia among Zambian pregnant women aged 15-49 in 2018. Despite WHO's endorsement of IPTp-SP to combat malaria-related anaemia, its prevalence continued to rise, significantly impacting maternal health. Methodology: Using Zambia Demographic Health Survey 2018 data, 665 pregnant women receiving IPTp-SP were analysed for haemoglobin levels, determining anaemia through blood tests. Statistical methods included survey-adjusted proportions, means, bivariate analysis, multiple linear regression, and multi-level ordinal logistic models with spatial random effects. Spatial analyses used ArcMap for coverage analysis, ordinary least squares, and geographically weighted regression maps (GWR) techniques in R and Stata. Results: Optimal IPTp-SP doses resulted in 36.98% anaemia prevalence (124/369), and suboptimal doses led to 42.85% (112/296). Factors associated with anaemia included household size, rich wealth index, high parity, and employment during pregnancy. Associations between IPTp-SP uptake and anaemia were identified: household size (four to six: AOR= 0.53; 95% CI 0.34 to 0.80; seven or more: AOR=0.57; 95% CI 0.35 to 0.91), adequate antenatal visits (AOR=0.68; 95% CI 0.48 to 0.97), and rich wealth index (AOR= 0.68; 95% CI 0.34 to 0.98). Spatial analysis revealed anaemia hotspots in Southern, Luapula, and Eastern provinces, with iron supplements and household size identified as influential factors. Conclusion: Despite IPTp-SP use, overall anaemia prevalence was 40%, with the highest rates in Southern, Luapula, and Western provinces. Targeted strategies focusing on improving iron tablet access, antenatal care attendance, and utilising spatial maps are crucial for mitigating adverse anaemia outcomes in these region
dc.description.submitterMM2024
dc.facultyFaculty of Health Sciences
dc.identifier.citationChisiba, Charlotte. (2024). The association between intermittent preventive treatment uptake and anaemia amongst pregnant women in Zambia in 2018: a spatial analysis [Master’s dissertation, University of the Witwatersrand, Johannesburg]. WireDSpace. https://hdl.handle.net/10539/42768
dc.identifier.urihttps://hdl.handle.net/10539/42768
dc.language.isoen
dc.publisherUniversity of the Witwatersrand, Johannesburg
dc.rights© 2024 University of the Witwatersrand, Johannesburg. All rights reserved. The copyright in this work vests in the University of the Witwatersrand, Johannesburg. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of University of the Witwatersrand, Johannesburg.
dc.rights.holderUniversity of the Witwatersrand, Johannesburg
dc.schoolSchool of Public Health
dc.subjectIntermittent Preventive Treatment Uptake
dc.subjectAnaemia
dc.subjectPregnant Women and Spatial Analysis
dc.subjectUCTD
dc.subject.otherSDG-3: Good health and well-being
dc.titleThe association between intermittent preventive treatment uptake and anaemia amongst pregnant women in Zambia in 2018: a spatial analysis
dc.typeDissertation
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Chishiba_Association_2024.pdf
Size:
2.02 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.43 KB
Format:
Item-specific license agreed upon to submission
Description: